본문 바로가기
KERD
논문KCI 등재

청아원가감 추출물이 난소적출로 유발된 흰쥐의 골다공증 모델이 미치는 영향

Effect of Cheongawongagam Extract on the Ovariectomized Rat Model of Osteoporosis

2

조회

0

다운로드

2

인용

0

참고문헌

키워드

주제분류한의학

초록

This study was conducted to evaluate the efficacy of Cheongawongagam on osteoporosis rat. A total of 35 rats were divided into seven groups; Normal control(SD-Nr), experimental control group(OVX-CTL), positive control group(OVX-17β-E2) and herb extracts group[Eucommia ulmoides(OVX-EU-E), Juglandis semen(OVX-JR-SE), Acanthopanax senticosus(OVX-AS-E) extract and Cheongawongagam extracts(OVX-JAEG-E)]. All control group, and herb extracts group were ovariectomized. After the 3 weeks recovery period, herb extract group were orally administered 200 mg / kg of the EU-E, JR-SE, AS-E and JAEG-E for 12 weeks. In the OVX-CTL, 17β-estradiol(E2) was administered subcutaneously on the back of the rats at a dose of 0.03 ug/sc. Their body weight, serum total cholesterol, triglyceride, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), Leukotriene B4 (LTB4), calcium (Ca), estradiol, osteocalcin, and deoxypyridinoline (DPD) concentration were measured. Also, we investigated mRNA expression of inflammatory cytokine, MMP-2, MMP-9, and bone tissue. As a result, total cholesterol was significantly decreased in the OVX-AS-E and OVX-JAEG-E. ALP was significantly increased and osteocalcin, DPD was significantly decreased in OVX-JAEG-E. The expression of inflammatory mediators (TNF-α, IL-1β, LTB4, COX-2, NOS-2), inflammatory cytokines IL-1β and MMP-9 mRNA were significantly decreased in OVX-JAEG-E. Histologic examination of the femur showed that bone mineral density, and bone mass were increased and bone marrow were decreased in the OVX-JAEG-E group. The above experiment shows that cheongawongagam extract were effective in the prevention and treatment of osteoporosis.

Abstract

This study was conducted to evaluate the efficacy of Cheongawongagam on osteoporosis rat. A total of 35 rats were divided into seven groups; Normal control(SD-Nr), experimental control group(OVX-CTL), positive control group(OVX-17β-E2) and herb extracts group[Eucommia ulmoides(OVX-EU-E), Juglandis semen(OVX-JR-SE), Acanthopanax senticosus(OVX-AS-E) extract and Cheongawongagam extracts(OVX-JAEG-E)]. All control group, and herb extracts group were ovariectomized. After the 3 weeks recovery period, herb extract group were orally administered 200 mg / kg of the EU-E, JR-SE, AS-E and JAEG-E for 12 weeks. In the OVX-CTL, 17β-estradiol(E2) was administered subcutaneously on the back of the rats at a dose of 0.03 ug/sc. Their body weight, serum total cholesterol, triglyceride, aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase (ALP), Leukotriene B4 (LTB4), calcium (Ca), estradiol, osteocalcin, and deoxypyridinoline (DPD) concentration were measured. Also, we investigated mRNA expression of inflammatory cytokine, MMP-2, MMP-9, and bone tissue. As a result, total cholesterol was significantly decreased in the OVX-AS-E and OVX-JAEG-E. ALP was significantly increased and osteocalcin, DPD was significantly decreased in OVX-JAEG-E. The expression of inflammatory mediators (TNF-α, IL-1β, LTB4, COX-2, NOS-2), inflammatory cytokines IL-1β and MMP-9 mRNA were significantly decreased in OVX-JAEG-E. Histologic examination of the femur showed that bone mineral density, and bone mass were increased and bone marrow were decreased in the OVX-JAEG-E group. The above experiment shows that cheongawongagam extract were effective in the prevention and treatment of osteoporosis.

참고문헌 (40)

  1. Korean society for bone and mineral research, "Osteoporosis", pp.11~17 (2006), Hanmi publishing
  2. 유제현, "Osteoporotic Fracture: 2015 Position Statement of the Korean Society for Bone and Mineral Research", 대한골대사학회지, 22(4), pp.175~181 (2015), 대한골대사학회
  3. 이성락, "고관절 주위골절로 인한 사망률 및 활동성 -전향적 연구-", 대한정형외과학회지, 40(4), pp.423~427 (2005), 대한정형외과학회
  4. 김이석, "노령 고관절 골절 예방을 위한 노력", 대한의사협회지, 59(8), pp.631~636 (2016), 대한의사협회[DOI]
  5. Kim JH, "Reviews of recent research on the osteoporosis-is mainly dependent on the oriental medicine clinical and experimental study", J Korean Acupunct Moxibustion Soc, 15(2), pp.437~454 (1998)
  6. The Korean orthopaedic association, "Orthopaedic" (1999), Choesin publishing
  7. Seo MS, "The Review on the Study of Osteoporosis in Korean Medicine Journals", J Korea CHUNA Man Med Spine Nerves, 8(2), pp.67~78 (2013)
  8. 김민범, "골다공증 연구에 사용되는 處方 및 本草에 관한 문헌 연구 - 2000년 이후 발표된 논문을 중심으로", 한방재활의학과학회지, 20(1), pp.91~107 (2010), 한방재활의학과학회
  9. J Huh, "Dogneui Bogam" (2005), Dongeuibogam publishing
  10. Kim SH, "Peroxynitrite Scavenging Activity and its Mechanism of Cheonga-hwan", J Korean Med, 23(4) (2002)
  11. Yun GW, "Effects of Korean herbal medicine (Cheong-A-Won) for treatment of bone mineral density in women with osteoporosis: A randomized, double blind, placebo controlled trial", Eur J Integr Med, 20, pp.84~89 (2018)
  12. Xu Y, "The Evaluation of Toxicity Induced by Psoraleae Fructus in Rats Using Untargeted Metabonomic Method Based on UPLC-Q-TOF", MS, 2017, pp.2017, ~
  13. HB Pyeonchanwiwonhoe, "Bonchohak", pp.325~326 (2004), Yeongrimsa
  14. 대한골대사학회 지침 위원회, "골다공증 진단 및 치료 지침 2007", Endocrinology and Metabolism, 23(2), pp.76~108 (2008), 대한내분비학회
  15. Yang KH, "Ageing society and osteoporosis", J Korean Med Assoc, 59(11), pp.833~835 (2016)
  16. 박소현, "저출산-고령사회 지역 인구구조 변화를 고려한 인구연령층별 관련 의료시설 분포 예측", 대한지리학회지, 53(3), pp.371~385 (2018), 대한지리학회
  17. Cosman F, "Clinician’s guide to prevention and treatment of osteoporosis", Osteoporos Int, 25(10), pp.2359~2381 (2014)
  18. Abrahamsen B, "Bisphosphonate adverse effects, lessons from large databases", Curr Opin Rheumatol, 22(4), pp.404~409 (2010)
  19. MacLean C, "Systematic review : comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis", Ann Intern Med, 148(3), pp.197~213 (2008)
  20. Do HK, "Donguisingyehak", pp.1144~1151 (1991)
  21. 김민수, "靑娥地黃湯이 卵巢摘出로 誘發된 흰쥐의 骨多孔症에 미치는 影響", 대한본초학회지, 18(2), pp.49~58 (2003), 대한본초학회
  22. 강재희, "청아원을 사용한 환자 278례에 대한 증례 분석", Journal of Acupuncture Research, 28(1), pp.93~100 (2011), 대한침구의학회
  23. Zhang R, "Du-Zhong (Eucommia ulmoides Oliv.) cortex extract prevent OVX-induced osteoporosis in rats", Bone, 45(3), pp.553~559 (2009)
  24. 정연태, "두충의 물 추출물이 파골세포의 분화에 미치는 영향", 동의생리병리학회지, 23(3), pp.613~618 (2009), 한의병리학회
  25. Papoutsi Z, "Walnut extract (Juglans regia L.) and its component ellagic acid exhibit anti-inflammatory activity in human aorta endothelial cells and osteoblastic activity in the cell line KS483", Br J Nutr, 99(4), pp.715~722 (2008)
  26. Hwang YC, "The effects of Acanthopanax senticosus extract on bone turnover and bone mineral density in Korean postmenopausal women", J Bone Miner Metab, 27(5), pp.584~590 (2009)
  27. Funk JL, "Effects of Ginger(Zingiber officialis L)on Inflammation-Induced Bone Loss" (2012), Federation of American Societies for Experimental Biology
  28. Fan JZ, "The effects of 6-gingerol on proliferation, differentiation, and maturation of osteoblast-like MG-63 cells", Brazilian J Med Biol Res, 48(7), pp.637~643 (2015)
  29. Kalu DN, "Effects of ovariectomy and estrogen on the serum levels of insulin-like growth factor-I and insulin-like growth factor binding protein-3", Bone Miner, 25(2), pp.135~148 (1994)
  30. Stevenson JC, "Influence of age and menopause on serum lipids and lipoproteins in healthy women", Atherosclerosis, 98(1), pp.83~90 (1993)
  31. Datta HK, "The cell biology of bone metabolism", J Clin Pathol, 61(5), pp.577~587 (2008)
  32. Naylor K, "Bone turnover markers : use in osteoporosis", Nat Rev Rheumatol, 8(7), pp.379~ (2012)
  33. Yeh JK, "Effects of 17β-estradiol replacement and treadmill exercise on vertebral and femoral bones of the ovariectomized rat", Bone Miner, 24(3), pp.223~234 (1994)
  34. Mundy GR, "Osteoporosis and inflammation", Nutr Rev, 65(suppl_3), pp.S147~S151 (2007)
  35. Pino AM, "Concentration of adipogenic and proinflammatory cytokines in the bone marrow supernatant fluid of osteoporotic women", J Bone Miner Res, 25(3), pp.492~498 (2010)
  36. Hammett-Stabler CA, "The use of biochemical markers in osteoporosis", Clin Lab Med, 24(1), pp.175~197 (2004)
  37. Notelovitz M, "Osteoporosis : screening, prevention, and management", Fertil Steril, 59(4), pp.707~725 (1993)
  38. Kim W, "Recent research of biochemical bone markers measurement in osteoporosis and clinical utility", pp.2015
  39. Choi SH, "The pattern of urinary deoxypyridinoline and serum osteocalcin across menopausal transition in women", J Korean Acad Fam Med, 21(12), pp.1552~1559 (2000)
  40. Nyman JS, "Differential effects between the loss of MMP-2 and MMP-9 on structural and tissue-level properties of bone", J Bone Miner Res, 26(6), pp.1252~1260 (2011)

관련 논문AI추천

이 간행물의 다른 논문 (7건)